Invivyd, Inc. - Common Stock
(NQ:
IVVD
)
0.9043
+0.0029 (+0.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Invivyd, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023
May 01, 2023
Via
Benzinga
Invivyd to Participate at H.C. Wainwright’s BioConnect Investor Conference
April 25, 2023
From
Invivyd
Via
GlobeNewswire
Invivyd Announces the FDA Has Cleared Its IND Application for VYD222, a Monoclonal Antibody Candidate for Prevention of COVID-19, and Provides Phase 1 VYD222 Clinical Trial Update
April 25, 2023
From
Invivyd
Via
GlobeNewswire
Invivyd Earnings Preview
March 22, 2023
Via
Benzinga
Invivyd Appoints Robert Allen as Chief Scientific Officer and Stacy Price as Chief Technology and Manufacturing Officer
April 12, 2023
From
Invivyd
Via
GlobeNewswire
Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) Investors of Class Action and Last Few Hours to Actively Participate
April 03, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
IVVD DEADLINE TOMORROW: ROSEN, A LEADING NATIONAL FIRM, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IVVD, ADGI
April 02, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
INVIVYD DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Invivyd, Inc. and Encourages Investors to Contact the Firm
March 31, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
INVIVYD 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Invivyd, Inc. – IVVD, ADGI
March 31, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD)
March 31, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
IVVD FINAL DEADLINE MONDAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI
March 30, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
Invivyd Doses First Participants in Phase 1 Trial of VYD222, a Novel Monoclonal Antibody Candidate for COVID-19
March 30, 2023
A clinical trial generating safety, pharmacokinetics, and dosing data with the goal of providing information to allow for rapid advancement into a pivotal Phase 3 trial
From
Invivyd
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against RYVYL, Invivyd, Honda, and Allianz and Encourages Investors to Contact the Firm
March 27, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
IVVD FINAL DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - IVVD, ADGI
March 26, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 24, 2023
Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50.
Via
Benzinga
Invivyd Reports Full Year 2022 Financial Results and Business Highlights
March 23, 2023
From
Invivyd
Via
GlobeNewswire
Earnings Scheduled For March 23, 2023
March 23, 2023
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter.
Via
Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Invivyd, Honda, Allianz, and Block and Encourages Investors to Contact the Firm
March 22, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Invivyd Publishes Model for Evaluating Biomarker Correlates of Protection for Monoclonal Antibodies Against Symptomatic COVID-19
March 22, 2023
From
Invivyd
Via
GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important April 3 Deadline in Securities Class Action - IVVD, ADGI
March 20, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
INVIVYD, INC. (NASDAQ: IVVD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (NASDAQ: IVVD)
March 20, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI
March 19, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against RYVYL, Invivyd, Honda, Allianz and Encourages Investors to Contact the Firm
March 17, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Invivyd to Host Conference Call Discussing Full Year 2022 Financial Results and Business Highlights
March 16, 2023
From
Invivyd
Via
GlobeNewswire
NASDAQ:IVVD Investor Notice: Deadline on April 3, 2023 in Lawsuit Against Invivyd, Inc. Coming Up
March 15, 2023
San Diego, CA -- (SBWIRE) -- 03/15/2023 -- A deadline is coming up on April 3, 2023 in the lawsuit filed for certain investors of Invivyd, Inc. (NASDAQ:IVVD) over alleged securities laws violations by...
Via
SBWire
INVIVYD, INC. (NASDAQ: IVVD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (NASDAQ: IVVD)
March 13, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against National Vision, RYVYL, Invivyd, and Honda and Encourages Investors to Contact the Firm
March 12, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IVVD, ADGI
March 11, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Invivyd, Inc. (IVVD) Investors and Encourages Investors to Contact the Firm Before April 3, 2023
March 10, 2023
From
Kirby McInerney LLP
Via
Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against National Vision, RYVYL, Invivyd, and Honda and Encourages Investors to Contact the Firm
March 06, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.